Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
QJM : Monthly Journal of the Association of Physicians|March 31, 1998
Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF)S J Stanworth, M Bhavnani, C Chattopadhya, et al.
Diagnostic Microbiology and Infectious Disease|March 3, 2009
Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patientsScott A Van Wart, David R Andes, Paul G Ambrose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!Paul G Ambrose, Sujata M Bhavnani, Evelyn J Ellis-Grosse, et al.
Journal of Clinical Pathology|April 1, 1996
An unusual association of Felty syndrome and TCR gamma delta lymphocytosisS J Stanworth, L Green, R S Pumphrey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003
Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogensSujata M Bhavnani, Jeffrey P Hammel, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trialsC M Rubino, S M Bhavnani, G Moeck, et al.
Pulmonary Pharmacology & Therapeutics|March 31, 2009
Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adultsC M Rubino, S M Bhavnani, P G Ambrose, et al.
Antimicrobial Agents and Chemotherapy|June 9, 2016
Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection ModelBrian VanScoy, Jennifer McCauley, Sujata M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variablesJeffrey P Hammel, Sujata M Bhavnani, Ronald N Jones, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reductionPaul G Ambrose, Sujata M Bhavnani, Brenda B Cirincione, et al.
Pageof 16